Status:
COMPLETED
Oral Polypodium Leucotomos for Melasma
Lead Sponsor:
University of Miami
Conditions:
Melasma
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Primary Objective: To determine whether there is improvement in the melasma of participants taking oral Polypodium Leucotomos Secondary Objective: To determine whether oral Polypodium Leucotomos is we...
Detailed Description
Polypodium Leucotomos is a fern, also known as Calaguala used by the natives of northern Honduras as a treatment against malignant tumors Used in Spain and Central America for the treatment of psorias...
Eligibility Criteria
Inclusion
- Healthy female subjects 18-50 years of age.
- Female subjects with epidermal melasma.
- Female subjects of child-bearing potential must have been willing to use an acceptable form of birth control for the duration of the study.
- Subjects with Fitzpatrick skin types II, III, \& IV
- Subjects enrolled in this trial had a 2 week washout period if on prior treatment for melasma.
Exclusion
- Pregnant or lactating
- Dermal Melasma
- Hormonal therapies less than or equal too 4 weeks prior to study
- Use of photosensitizing medications
- Simultaneous use of any form of treatment for melasma
- Subjects who were concurrently receiving light therapies
- Subjects who were unwilling to limit the amount of sun exposure
- Simultaneous ( or past 30 day) participation in a clinical research study.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01162850
Start Date
May 1 2008
End Date
June 1 2009
Last Update
August 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami Cosmetic Center
Miami, Florida, United States, 33140